Expanding Orthopedics was granted its 14th U.S. Patent, covering 3D expandable cage technology integrated in the FLXfit™. Specifically, the patent addresses the multiple segment design with its articulation mechanism, and the angular expansion for dial-in lordosis correction.
FLXfit received CE Mark Approval and FDA 510(k) clearance in 2014, with initial procedures occurring within the same year.
Expanding Orthopedics was granted its 14th U.S. Patent, covering 3D expandable cage technology integrated in the FLXfit™. Specifically, the patent addresses the multiple segment design with its articulation mechanism, and the angular expansion for dial-in lordosis correction.
FLXfit received CE Mark Approval and FDA 510(k)...
Expanding Orthopedics was granted its 14th U.S. Patent, covering 3D expandable cage technology integrated in the FLXfit™. Specifically, the patent addresses the multiple segment design with its articulation mechanism, and the angular expansion for dial-in lordosis correction.
FLXfit received CE Mark Approval and FDA 510(k) clearance in 2014, with initial procedures occurring within the same year.
Copy to clipboard 
